Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
J Neurotrauma. 2012 Apr 10;29(6):1126-39. doi: 10.1089/neu.2011.2272.
The Glasgow Outcome Scale (GOS) and its most recent revision, the GOS-Extended (GOS-E), provide the gold standard for measuring traumatic brain injury (TBI) outcome. The GOS-E exhibits validity when used with adults and some adolescents, but validity with younger children is not established. Because the GOS-E lacks the developmental specificity necessary to evaluate children, toddlers, and infants, we modified the original version to create the GOS-E Pediatric Revision (GOS-E Peds), a developmentally appropriate structured interview, to classify younger patients. The criterion, predictive, and discriminant validity of the GOS-E Peds was measured in 159 subjects following TBI (mild: 36%; moderate: 12%; severe: 50%) at 3 and 6 months after injury. Participants were included from two studies completed at the Pediatric Neurotrauma Center at Children's Hospital of Pittsburgh. We assessed the relationship among GOS-E Peds, the GOS, and the Vineland Adaptive Behavior Scales as well as other standardized measures of functional, behavioral, intellectual, and neuropsychological outcome. Premorbid function was assessed 24-36 h after injury. The GOS-E Peds showed a strong correlation with the GOS at 3 and 6 month time points. Criterion-related validity was also indicated by GOS-E Peds' association with most measures at both time points and at injury severity levels. The 3 month GOS-E Peds was associated with the 6 month GOS-E Peds, everyday function, behavior, and most cognitive abilities. Discriminant validity is suggested by weak correlations between both 3 and 6 month GOS-E Peds and premorbid measures. The GOS-E Peds is sensitive to severity of injury and is associated with changes in TBI sequelae over time. This pediatric revision provides a valid outcome measure in infants, toddlers, children, and adolescents through age 16. Findings support using the GOS-E Peds as the primary outcome variable in pediatric clinical trials.
格拉斯哥结局量表(GOS)及其最近的修订版 GOS-扩展量表(GOS-E)是衡量创伤性脑损伤(TBI)结局的金标准。GOS-E 在用于成人和一些青少年时具有有效性,但在年幼儿童中尚未确定其有效性。由于 GOS-E 缺乏评估儿童、学步儿童和婴儿所需的发展特异性,我们对原始版本进行了修改,创建了 GOS-E 儿科修订版(GOS-E Peds),这是一种发展适当的结构化访谈,用于分类年幼患者。我们在创伤后 3 个月和 6 个月的 159 名 TBI 患者(轻度:36%;中度:12%;重度:50%)中测量了 GOS-E Peds 的标准、预测和判别有效性。参与者来自匹兹堡儿童医院儿科神经创伤中心完成的两项研究。我们评估了 GOS-E Peds、GOS 和 Vineland 适应行为量表之间的关系,以及其他功能、行为、智力和神经心理学结局的标准化测量。在受伤后 24-36 小时评估了预患病功能。GOS-E Peds 在 3 个月和 6 个月时与 GOS 具有很强的相关性。在两个时间点和损伤严重程度水平上,GOS-E Peds 与大多数测量方法的关联也表明了其具有标准关联有效性。3 个月的 GOS-E Peds 与 6 个月的 GOS-E Peds、日常功能、行为和大多数认知能力相关。3 个月和 6 个月的 GOS-E Peds 与预患病测量之间的弱相关性表明了其具有判别有效性。GOS-E Peds 对损伤严重程度敏感,并与 TBI 后遗症随时间的变化相关。该儿科修订版在 16 岁以下的婴儿、幼儿、儿童和青少年中提供了有效的结局测量。研究结果支持在儿科临床试验中使用 GOS-E Peds 作为主要结局变量。